A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)

NCT00130793 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

368

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: Comparator: zoster vaccine live (Oka/Merck) refrigerated formulation
BIOLOGICAL: Comparator: zoster vaccine live (Oka/Merck) frozen formulation

Sponsor

Merck Sharp & Dohme LLC